Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To assess the immunological response to a booster dose of GSK Biologicals’ IPV in terms of poliovirus type 1, 2 and 3 antibodies, one month after the booster dose in subjects primed with three doses of the same IPV vaccine in study IPV-018. To assess the persistence of antibodies to poliovirus types 1, 2 and 3 antigens at 18 months of age in subjects primed with three doses of GSK Biologicals’ IPV or three doses of OPV in study IPV-018.
Inclusion criteria
- Booster immunisation of healthy children in the second year of life against poliomyelitis